Latest Car T News

MONEYME reported a robust start to FY26 with a 26% increase in its loan book and improved credit metrics, driven by strong originations and strategic product expansions.

AdAlta Limited has fully repaid its remaining NLSC investment in cash, ending its obligation to issue further shares and positioning itself for private capital raises to advance its CAR-T therapies.

Plenti Group Limited has reported a fourth straight quarter of record loan originations, driving a 24% annual growth in its loan portfolio and doubling its half-year profits. The fintech lender is accelerating towards a $3 billion loan book target by March 2026 amid strong credit performance and strategic investments.

AdAlta Limited has raised up to A$1.1 million through a private placement, boosting its war chest to advance innovative cellular immunotherapy projects targeting solid cancers.

PARKD Limited has successfully closed its Share Purchase Plan, raising $220,000; well above the initial $120,000 target; following a recent $780,000 placement. This capital boost underscores strong shareholder confidence in the company’s innovative building solutions.

INOVIQ Limited has completed a $9.5 million placement to institutional investors and launched a $2 million Share Purchase Plan for existing shareholders, aiming to bolster its cancer diagnostics and therapeutics pipeline.

Jumbo Interactive has acquired UK-based Dream Car Giveaways for A$109.9 million, marking its entry into the fast-growing UK prize draw market and establishing a significant B2C presence internationally.

Jumbo Interactive has completed a strategic acquisition of UK-based Dream Car Giveaways, marking its entry into the rapidly growing UK prize draw market. The deal, valued at nearly A$110 million, positions Jumbo to leverage its digital lottery expertise internationally.

JAYRIDE Group Limited has partnered with Xoomplay to integrate in-vehicle media and advertising into its SaaS platform, aiming to transform vehicles into dynamic media assets across Southeast Asia and Australasia.

Baby Bunting has reported record FY25 results and reaffirmed its FY26 guidance, driven by strong sales growth and the ongoing Store of the Future refurbishment program. The company is expanding both large and small format stores, aiming to return to a +10% EBITDA margin business.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

AdAlta Limited has raised up to A$0.5 million through a premium-priced private placement, bolstering its 'East to West' cellular immunotherapy strategy focused on advancing CAR-T therapies for solid cancers.